Department of Psychology, Illinois Institute of Technology, Chicago, IL, USA.
Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
J Psychiatr Res. 2022 Feb;146:156-162. doi: 10.1016/j.jpsychires.2021.12.020. Epub 2021 Dec 14.
Despite emerging evidence linking obsessive-compulsive disorder and symptoms (OCS) and nicotine dependence (ND), this comorbidity has received little research. To address this, the current investigation highlights evidence of this comorbidity in two epidemiologic datasets: (1) US nationally-representative survey (i.e., National Comorbidity Study-Replication; NCS-R), and (2) a psychiatric clinical epidemiology dataset (i.e., the Methods to Improve Diagnostic Assessment and Services; MIDAS). For NCS-R (n = 2088), interviews were carried as part of extensive data collection, including OCS symptom count and ND diagnosis. For MIDAS (n = 1257), as part of receiving mental health services at a US hospital outpatient treatment program, participants received diagnostic interviews, including evaluation of ND and obsessive-compulsive disorder (OCD), with OCS being characterized by self-reported symptom count. Results from NCS-R indicate that rates of current ND increased from 3.1% to 10.8% as OCS symptom count increased. Results from the MIDAS clinical sample exhibited a similar trend, but with higher overall figures compared to the US-representative NCS-R sample, with rates of current ND increasing from 18.3% to 41.4% as OCS count increased. In both datasets, OCS was positively associated with current (but not prior) ND after adjusting for psychiatric and sociodemographic covariates. For MIDAS, after adjusting for covariates, OCD diagnostic status was not associated with ND. Findings from this study lend support for the OCS-ND comorbidity in clinical and non-clinical populations and suggests that the OCS-ND link may be obscured when obsessive-compulsive phenomena is modeled as a dichotomous diagnostic variable versus as a dimensional construct.
尽管有越来越多的证据表明强迫症和症状(OCS)与尼古丁依赖(ND)有关,但这种共病现象的研究却很少。为了解决这个问题,目前的研究在两个流行病学数据集上强调了这种共病的证据:(1)美国全国代表性调查(即国家共病研究-复制;NCS-R),以及(2)精神病临床流行病学数据集(即改善诊断评估和服务的方法;MIDAS)。对于 NCS-R(n=2088),作为广泛数据收集的一部分进行了访谈,包括 OCS 症状计数和 ND 诊断。对于 MIDAS(n=1257),作为在美国医院门诊治疗计划接受心理健康服务的一部分,参与者接受了诊断访谈,包括 ND 和强迫症(OCD)的评估,OCS 通过自我报告的症状计数来描述。NCS-R 的结果表明,随着 OCS 症状计数的增加,当前 ND 的发生率从 3.1%增加到 10.8%。MIDAS 临床样本的结果也表现出类似的趋势,但与 NCS-R 代表性样本相比,总体数字更高,随着 OCS 计数的增加,当前 ND 的发生率从 18.3%增加到 41.4%。在两个数据集,OCS 在调整精神病学和社会人口统计学协变量后,与当前(但不是以前)ND 呈正相关。对于 MIDAS,在调整协变量后,OCD 诊断状况与 ND 无关。这项研究的结果为临床和非临床人群中 OCS-ND 共病提供了支持,并表明当将强迫现象建模为二分类诊断变量而不是维度结构时,OCS-ND 之间的联系可能会被掩盖。